Granulation tissue-induced pseudo-relapse during nivolumab treatment in advanced non-small cell lung cancer

Chihiro Ando, Eiki Ichihara, Hirohisa Kano, Yoshitaka Iwamoto, Atsuko Hirabae, Takamasa Nakasuka, Yoshinobu Maeda, Katsuyuki Kiura

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Atypical tumor responses such as pseudo-progression or hyper-progression sometimes occur during immune check point inhibitor therapy. Distinct from both responses, we experienced a case of non-small cell lung cancer (NSCLC) with a pseudo-relapse, in which development of granulation mimicked cancer relapse during nivolumab therapy. A male with advanced NSCLC started nivolumab as a second-line therapy. After 15 cycles of nivolumab with a complete response, tumor markers started increasing and positron-emission computed tomography indicated a hot spot in the sigmoid colon. Laparoscopic segmental sigmoid colon resection revealed granulation tissue without any relapse of malignant cells. The results showed that even if radiographical tumor progression is found during immune therapy, histological confirmation should be considered.

Original languageEnglish
Pages (from-to)2113-2115
Number of pages3
JournalIn Vivo
Volume33
Issue number6
DOIs
Publication statusPublished - Jan 1 2019

Fingerprint

Granulation
Granulation Tissue
Non-Small Cell Lung Carcinoma
Cells
Tissue
Recurrence
Tumors
Sigmoid Colon
Emission-Computed Tomography
Positrons
Tumor Biomarkers
Neoplasms
Tomography
Therapeutics
Positron-Emission Tomography
nivolumab

Keywords

  • Granulation tissue
  • Immune checkpoint inhibitors
  • Lung cancer
  • Nivolumab

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology

Cite this

Granulation tissue-induced pseudo-relapse during nivolumab treatment in advanced non-small cell lung cancer. / Ando, Chihiro; Ichihara, Eiki; Kano, Hirohisa; Iwamoto, Yoshitaka; Hirabae, Atsuko; Nakasuka, Takamasa; Maeda, Yoshinobu; Kiura, Katsuyuki.

In: In Vivo, Vol. 33, No. 6, 01.01.2019, p. 2113-2115.

Research output: Contribution to journalArticle

Ando, Chihiro ; Ichihara, Eiki ; Kano, Hirohisa ; Iwamoto, Yoshitaka ; Hirabae, Atsuko ; Nakasuka, Takamasa ; Maeda, Yoshinobu ; Kiura, Katsuyuki. / Granulation tissue-induced pseudo-relapse during nivolumab treatment in advanced non-small cell lung cancer. In: In Vivo. 2019 ; Vol. 33, No. 6. pp. 2113-2115.
@article{023243b142774c6caf11c8f9776102eb,
title = "Granulation tissue-induced pseudo-relapse during nivolumab treatment in advanced non-small cell lung cancer",
abstract = "Atypical tumor responses such as pseudo-progression or hyper-progression sometimes occur during immune check point inhibitor therapy. Distinct from both responses, we experienced a case of non-small cell lung cancer (NSCLC) with a pseudo-relapse, in which development of granulation mimicked cancer relapse during nivolumab therapy. A male with advanced NSCLC started nivolumab as a second-line therapy. After 15 cycles of nivolumab with a complete response, tumor markers started increasing and positron-emission computed tomography indicated a hot spot in the sigmoid colon. Laparoscopic segmental sigmoid colon resection revealed granulation tissue without any relapse of malignant cells. The results showed that even if radiographical tumor progression is found during immune therapy, histological confirmation should be considered.",
keywords = "Granulation tissue, Immune checkpoint inhibitors, Lung cancer, Nivolumab",
author = "Chihiro Ando and Eiki Ichihara and Hirohisa Kano and Yoshitaka Iwamoto and Atsuko Hirabae and Takamasa Nakasuka and Yoshinobu Maeda and Katsuyuki Kiura",
year = "2019",
month = "1",
day = "1",
doi = "10.21873/invivo.11711",
language = "English",
volume = "33",
pages = "2113--2115",
journal = "In Vivo",
issn = "0258-851X",
publisher = "International Institute of Anticancer Research",
number = "6",

}

TY - JOUR

T1 - Granulation tissue-induced pseudo-relapse during nivolumab treatment in advanced non-small cell lung cancer

AU - Ando, Chihiro

AU - Ichihara, Eiki

AU - Kano, Hirohisa

AU - Iwamoto, Yoshitaka

AU - Hirabae, Atsuko

AU - Nakasuka, Takamasa

AU - Maeda, Yoshinobu

AU - Kiura, Katsuyuki

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Atypical tumor responses such as pseudo-progression or hyper-progression sometimes occur during immune check point inhibitor therapy. Distinct from both responses, we experienced a case of non-small cell lung cancer (NSCLC) with a pseudo-relapse, in which development of granulation mimicked cancer relapse during nivolumab therapy. A male with advanced NSCLC started nivolumab as a second-line therapy. After 15 cycles of nivolumab with a complete response, tumor markers started increasing and positron-emission computed tomography indicated a hot spot in the sigmoid colon. Laparoscopic segmental sigmoid colon resection revealed granulation tissue without any relapse of malignant cells. The results showed that even if radiographical tumor progression is found during immune therapy, histological confirmation should be considered.

AB - Atypical tumor responses such as pseudo-progression or hyper-progression sometimes occur during immune check point inhibitor therapy. Distinct from both responses, we experienced a case of non-small cell lung cancer (NSCLC) with a pseudo-relapse, in which development of granulation mimicked cancer relapse during nivolumab therapy. A male with advanced NSCLC started nivolumab as a second-line therapy. After 15 cycles of nivolumab with a complete response, tumor markers started increasing and positron-emission computed tomography indicated a hot spot in the sigmoid colon. Laparoscopic segmental sigmoid colon resection revealed granulation tissue without any relapse of malignant cells. The results showed that even if radiographical tumor progression is found during immune therapy, histological confirmation should be considered.

KW - Granulation tissue

KW - Immune checkpoint inhibitors

KW - Lung cancer

KW - Nivolumab

UR - http://www.scopus.com/inward/record.url?scp=85074194652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85074194652&partnerID=8YFLogxK

U2 - 10.21873/invivo.11711

DO - 10.21873/invivo.11711

M3 - Article

C2 - 31662545

AN - SCOPUS:85074194652

VL - 33

SP - 2113

EP - 2115

JO - In Vivo

JF - In Vivo

SN - 0258-851X

IS - 6

ER -